The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
Open accessAbstract
BACKGROUND: Restricting protein intake and controlling hypertension delay the progression of renal disease in animals. We tested these interventions in 840 patients with various chronic renal diseases. METHODS: In study 1, 585 patients with glomerular filtration rates of 25 to 55 ml per minute per 1.73 m2 of body-surface area were randomly assigned to a usual-protein diet or a low-protein diet (1.3 or 0.58 g of protein per kilogram of body weight per day) and to a usual- or a low-blood-pressure group (mean arterial pressure, 107 or 92 mm Hg). In study 2, 255 patients with glomerular filtration rates of 13 to 24 ml per minute per 1.73 m2 were randomly assigned to the low-protein diet (0.58 g per kilogram per day) or a very-low-protein diet (0.28 g per kilogram per day) with a keto acid-amino acid supplement, and a usual- or a low-blood-pressure group (same values as those in study 1). An 18-to-45-month follow-up was planned, with monthly evaluations of the patients. RESULTS: The mean follow-up was 2.2 years. In study 1, the projected mean decline in the glomerular filtration rate at three years did not differ significantly between the diet groups or between the blood-pressure groups. As compared with the usual-protein group and the usual-blood-pressure group, the low-protein group and the low-blood-pressure group had a more rapid decline in the glomerular filtration rate during the first four months after randomization and a slower decline thereafter. In study 2, the very-low-protein group had a marginally slower decline in the glomerular filtration rate than did the low-protein group (P = 0.07). There was no delay in the time to the occurrence of end-stage renal disease or death. In both studies, patients in the low-blood-pressure group who had more pronounced proteinuria at base line had a significantly slower rate of decline in the glomerular filtration rate. CONCLUSIONS: Among patients with moderate renal insufficiency, the slower decline in renal function that started four months after the introduction of a low-protein diet suggests a small benefit of this dietary intervention. Among patients with more severe renal insufficiency, a very-low-protein diet, as compared with a low-protein diet, did not significantly slow the progression of renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with a noneproteinlimited diet, a low-protein diet of 0.6 g/kg BW/d can prevent a decline in GFR of approximately 1 mL/min per year per 1.73 m 2 and is associated with a 30% decrease in reaching a dialysisdependent stage.114,115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reducing the amount of dietary protein below the recommended daily allowance of 0.8 g/kg/day is not recommended because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (46).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with CKD and diabetes, consuming protein below the recommended daily allowance of 0.8 g/kg/day is not recommended, because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (48).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Under those conditions, the development of malnutrition during a low-protein diet is an extremely rare event.115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,974
Anthropometric standards for the assessment of growth and nutritional status
(1991) · Clinical Nutrition · doi:10.1016/0261-5614(91)90103-j · Cited by 1,197
The modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J., Hunsicker, L. G., SCHLUCHTER, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Self-citationA method for estimating nitrogen intake of patients with chronic renal failure
Maroni, B. J., Steinman, T. I., & Mitch, W. E. (1985) · Kidney International · doi:10.1038/ki.1985.10 · Cited by 789
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
Brenner, P. D. B. M. (1983) · Kidney International · doi:10.1038/ki.1983.72 · Cited by 617
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J. B., ter Wee, P. M., Truus, S. M., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 554
The Modification of Diet in Renal Disease Study
Klahr, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201310 · Cited by 454
Self-citation
Research works printed but not linked: 6
- Hunsicker LG, 1989, Semin Nephrol, 9, 380
- 10.1001/archinte.153.2.154 · DOI
- Levey AS, 1989, Kidney Int Suppl, 27, S
- Kopple JD, 1989, Kidney Int Suppl, 27, S
- Greene T, 1993, J Am Soc Nephrol, 3, 1819
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 1,000
Documento de información y consenso para la detección y manejo de la enfermedad renal crónica
Maset, R. G., Bover, J., Segura, J., Diezhandino, M. G., del Hoyo, J. C., Martín, J. E. S., Fácila, L., Gamarra, J., García‐Donaire, J. A., Matarin, L. G., et al. (2021) · Nefrología · doi:10.1016/j.nefro.2021.07.010 · Cited by 160
Cianciaruso, B., Pota, A., Pisani, A., Torraca, S., Annecchini, R., Lombardi, P., Capuano, A., Nazzaro, P., Bellizzi, V., & Sabbatini, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm576 · Cited by 122
Fischer, M. J., Go, A. S., Lora, C. M., Ackerson, L., Cohan, J., Kusek, J. W., Mercado, A., OJO, A. O., Ricardo, A. C., Rosen, L., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.010 · Cited by 120
Self-citationAkbari, A., Clase, C. M., Acott, P., Battistella, M., Bello, A. K., Feltmate, P., Grill, A. K., Karsanji, M., Komenda, P. V. J., Madore, F., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.10.013 · Cited by 125
Greene, T., Ying, J., Vonesh, E. F., Tighiouart, H., Levey, A. S., Coresh, J., Herrick, J. S., Imai, E., Jafar, T. H., Maes, B., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019010009 · Cited by 120
Self-citationBorzecki, A. M., Wong, A. T., Hickey, E. C., Ash, A. S., & Berlowitz, D. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2705 · Cited by 120
Chuahirun, T., & Wesson, D. E. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.30559 · Cited by 121
Mix, T.-C. H., Brenner, R. M., Cooper, M. E., de Zeeuw, D., Ivanovich, P. T., Levey, A. S., McGill, J. B., McMurray, J. J. V., Parfrey, P. S., Parving, H., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.09.047 · Cited by 119
Self-citationThe Western Diet and Chronic Kidney Disease
Hariharan, D., Vellanki, K., & Kramer, H. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0529-6 · Cited by 122
Benefits of dietary sodium restriction in the management of chronic kidney disease
Krikken, J. A., Laverman, G. D., & Navis, G. J. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283312fc8 · Cited by 120
Yan, B., Su, X., Xu, B., Qiao, X., & Wang, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206134 · Cited by 134
Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients
Shemin, D. G., Maaz, D., Pierre, D. S., Kahn, S. I., & Chazan, J. A. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70102-2 · Cited by 118
Does predialysis nephrology care influence patient survival after initiation of dialysis?
Khan, S. S., Xue, J. L., Kazmi, W., Gilbertson, D. T., Obrador, G. T., Pereira, B. J. G., & Collins, A. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00168.x · Cited by 118
Low protein diets delay end‐stage renal disease in non‐diabetic adults with chronic renal failure
Fouque, D. P., Wang, P., Laville, M., & Boissel, J. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.1986 · Cited by 118
Low protein diets for chronic kidney disease in non diabetic adults
Fouque, D. P., Laville, M., & Boissel, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001892.pub2 · Cited by 118
Liu, C.-T., Garnaas, M., Tin, A., Köttgen, A., Franceschini, N., Peralta, C. A., de Boer, I. H., Lu, X., Atkinson, E. J., Ding, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002264 · Cited by 117
Long-Term Deterioration of Kidney Allograft Function
Kasiske, B. L., Gaston, R. S., Gourishankar, S., Halloran, P. F., Matas, A. J., Jeffery, J., & Rush, D. N. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00853.x · Cited by 115
Cardiovascular disease in chronic renal failure: the challenge continues
Locatelli, F., Marcelli, D., Conte, F., DʼAmico, M., Vecchio, L. D., Limido, A., Malberti, F., & Spotti, D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.suppl_5.69 · Cited by 117
A.S.P.E.N. Clinical Guidelines
Brown, R. O., Compher, C. W., & American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110374577 · Cited by 115
Angiotensin-Converting Enzyme Inhibitors
Izzo, J. L., & Weir, M. R. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00508.x · Cited by 124
Metges, C. C., & Barth, C. A. (2000) · Journal of Nutrition · doi:10.1093/jn/130.4.886 · Cited by 113
Maione, A., Navaneethan, S. D., Graziano, G., Mitchell, R. L., Johnson, D. W., Mann, J. F. E., Gao, P., Craig, J. C., Tognoni, G., Perkovic, V., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq792 · Cited by 114
Samuelsson, O. G., Attman, P.-O., Knight‐Gibson, C., Larsson, R., Mulec, H., Weiss, L. G., & Alaupovic, P. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v981482 · Cited by 112
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea
Bankir, L., Roussel, R., & Bouby, N. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00614.2014 · Cited by 113
1999 Canadian recommendations for the management of hypertension
Feldman, R. D., Campbell, N. R. C., Larochelle, P. M., Bolli, P., Burgess, E. D., Carruthers, S. G., Floras, J. S., Haynes, R. B., Honos, G. N., Leenen, F. H. H., et al. (1999) · Europe PMC (PubMed Central) · Cited by 110
Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
Agarwal, R., Siva, S., Dunn, S., & Sharma, K. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31392 · Cited by 109
Feldman, R. D., Campbell, N. R. C., Larochelle, P. M., Bolli, P., Burgess, E. D., Carruthers, S. G., Floras, J. S., Haynes, R. B., Honos, G. N., Leenen, F. H. H., et al. (1999) · PubMed · Cited by 108
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s011 · Cited by 108
Therapeutic strategies to slow chronic kidney disease progression
Wühl, E., & Schaefer, F. S. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0789-y · Cited by 109
Effect of a High-Protein Diet on Kidney Function in Healthy Adults: Results From the OmniHeart Trial
Juraschek, S. P., Appel, L. J., Anderson, C. A. M., & Miller, E. R. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.10.017 · Cited by 114
Effects of Molidustat in the Treatment of Anemia in CKD
Macdougall, I. C., Akizawa, T., Berns, J. S., Bernhardt, T., & Krueger, T. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02510218 · Cited by 107
Class differences in the effects of calcium channel blockers in the rat remnant kidney model
Griffin, K. A., Picken, M. M., Bakris, G. L., & BIDANI, A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00434.x · Cited by 106
Orth, S. R. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045708 · Cited by 106
A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression
Cao, W., Li, A., Wang, L., Zhou, Z., Su, Z., Wei, B., Wilcox, C. S., & Hou, F. F. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050518 · Cited by 106
The Change in Allograft Function among Long-Term Kidney Transplant Recipients
Gill, J. S., Tonelli, M. A., Mix, C. H., & Pereira, B. J. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070621.06264.86 · Cited by 105
Effects of a Supplemented Hypoproteic Diet in Chronic Kidney Disease
Mircescu, G., Gârneaţă, L., Stancu, S. H., & Căpuşă, C. S. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.12.012 · Cited by 104
Relationship between Blood Pressure and Incident Chronic Kidney Disease in Hypertensive Patients
Hanratty, R. L., Chonchol, M., Havranek, E. P., Powers, J. D., Dickinson, L. M., Ho, P. M., Magid, D. J., & Steiner, J. F. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02240311 · Cited by 109
Koppe, L., & Fouque, D. P. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.016 · Cited by 107
Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease
Stanton, R. C. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.050 · Cited by 106
González-Campoy, J. M., Jeor, S. T. S., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.esgl · Cited by 102
Jhee, J. H., Kee, Y. K., Park, S., Kim, H., Park, J. T., Han, S. H., Kang, S., & Yoo, T. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz115 · Cited by 110
González-Campoy, J. M., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Jeor, S. T. S., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.gl · Cited by 107
Nutrition and growth in relation to severity of renal disease in children
Norman, L. J., Coleman, J. E., Macdonald, I. A., Tomsett, A., & Watson, A. R. (2000) · Pediatric Nephrology · doi:10.1007/s004670000465 · Cited by 100
Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy
Ardissino, G., Testa, S., Daccò, V., Vigan�, S., Taioli, E., Claris-Appiani, A., Procaccio, M., Avolio, L., Ciofani, A., Strologo, L. D., et al. (2004) · Pediatric Nephrology · doi:10.1007/s00467-003-1268-0 · Cited by 100
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 99
Ninomiya, T., Kiyohara, Y., Kubo, M., Tanizaki, Y., Tanaka, K., Okubo, K., Nakamura, H., Hata, J., Oishi, Y., Kato, I., et al. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00813-3 · Cited by 99
Hsu, C.-Y., McCulloch, C., Darbinian, J., Go, A., & Iribarren, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080814 · Cited by 98
Effect of Dietary Protein Supplementation on Blood Pressure
He, J., Wofford, M. R., Reynolds, K., Chen, J., Chen, C.-S., Myers, L., Minor, D. L., Elmer, P. J., Jones, D. W., & Whelton, P. K. (2011) · Circulation · doi:10.1161/circulationaha.110.009159 · Cited by 98
Dietary Approaches in the Management of Diabetic Patients with Kidney Disease
Ko, G. J., Kalantar‐Zadeh, K., Goldstein‐Fuchs, J., & Rhee, C. M. (2017) · Nutrients · doi:10.3390/nu9080824 · Cited by 101
Marincek, N., Radojewski, P., Dumont, R. A., Brunner, P., Müller‐Brand, J., Maëcke, H. R., Briel, M., & Walter, M. A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147256 · Cited by 97
Kubo, M., Kiyohara, Y., Kato, I., Tanizaki, Y., Katafuchi, R., Hirakata, H., Okuda, S., Tsuneyoshi, M., Sueishi, K., Fujishima, M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00886.x · Cited by 97
Kitada, M., Ogura, Y., Suzuki, T., Sen, S., Lee, S. M., Kanasaki, K., Kume, S., & Koya, D. (2016) · Diabetologia · doi:10.1007/s00125-016-3925-4 · Cited by 97
The pathobiology of polycystic kidney disease from a metabolic viewpoint
Menezes, L. F., & Germino, G. G. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0183-y · Cited by 96
Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease
Young, J. A. M., Terrin, N. C., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Sarnak, M. J., & Menon, V. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06671208 · Cited by 96
Self-citationAdvanced Glycation End Products and Nephrotoxicity of High-Protein Diets
Uribarri, J., & Tuttle, K. R. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01270406 · Cited by 96
Keenan, K. P., Soper, K. A., Hertzog, P. R., Gumprecht, L. A., Smith, P. F., Mattson, B. A., Ballam, G. C., & Clark, R. L. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300306 · Cited by 96
Kidney function in older people: pathology, assessment and management
Lamb, E. J., O'Riordan, S. E., & Delaney, M. P. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00246-8 · Cited by 97
Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience
Parving, H., Rossing, P. R., Hommel, E. E., & Smidt, U. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90162-0 · Cited by 96
High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function
Halbesma, N., Bakker, S. J. L., Jansen, D. F., Stolk, R. P., De Zeeuw, D., De Jong, P. E., & Gansevoort, R. T. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060649 · Cited by 95
Kovesdy, C. P., Lü, J., Molnar, M. Z., Ma, J. Z., Canada, R. B., Streja, E., Kalantar‐Zadeh, K., & Bleyer, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3279 · Cited by 95
Effects of multidisciplinary case management in patients with chronic renal insufficiency
Harris, L., Luft, F. C., Rudy, D., Kesterson, J. G., & Tierney, W. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00329-5 · Cited by 93
Severe dietary protein restriction in overt diabetic nephropathy: Benefits or risks?
Meloni, C., Morosetti, M., SURACI, C., Pennafina, M. G., Tozzo, C., TACCONE-GALLUCCI, M., & Casciani, C. U. (2002) · Journal of Renal Nutrition · doi:10.1053/jren.2002.31762 · Cited by 94
Empirical aminoglycosides for peritonitis do not affect residual renal function
Baker, R. J., Senior, H., Clemenger, M., & Brown, E. A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50129 · Cited by 95
Blood Pressure Control in Chronic Kidney Disease
Lewis, J. B. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030236 · Cited by 94
Ameliorating Chronic Kidney Disease Using a Whole Food Plant-Based Diet
Adair, K. E., & Bowden, R. G. (2020) · Nutrients · doi:10.3390/nu12041007 · Cited by 101
Consequences of late referral of patients with end‐stage renal disease
Gøransson, L. G., & Bergrem, H. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00869.x · Cited by 94
Milas, N. C., Nowalk, M. P., Akpele, L., CASTALDO, L., COYNE, T., DOROSHENKO, L., KIGAWA, L., Korzec-Ramirez, D., SCHERCH, L. K., & Snetselaar, L. G. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00340-1 · Cited by 94
Rahman, M., Ford, C. E., Cutler, J. A., Davis, B. R., Piller, L. B., Whelton, P. K., Wright, J. T., Barzilay, J. I., Brown, C. D., Colon, P. J., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07800811 · Cited by 95
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Saiz, L. C., Gorricho, J., Garjón, J., Celaya, M. C., Muruzábal, L., Malón, M. D. M., Montoya, R., & López, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010315.pub2 · Cited by 93
Masked Uncontrolled Hypertension in CKD
Agarwal, R., Pappas, M. K., & Sinha, A. D. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030243 · Cited by 94
Potassium Metabolism and Management in Patients with CKD
Yamada, S., & Inaba, M. (2021) · Nutrients · doi:10.3390/nu13061751 · Cited by 101
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease
Marín, R., Ruilope, L. M., Aljama, P., Aranda, P. J., Segura, J., & Dı́ez, J. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00023 · Cited by 92
Epidemiology and Risk Factors for Chronic Kidney Disease
McClellan, W. M. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.11.006 · Cited by 97
Hypertension and kidney disease: A deadly connection
Barri, Y. M. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0009-y · Cited by 92
Gassman, J., Greene, T., Wright, J. T., Agodoa, L. Y. C., Bakris, G. L., Beck, G. J., Douglas, J. G., Jamerson, K., Lewis, J. B., Kutner, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070080.21680.cb · Cited by 92
Self-citationGiglio, J., Silva, M. I. B., Qureshi, A. R., Bregman, R., Cervante, V. F., Carrero, J. J., & Avesani, C. M. (2012) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2012.10.004 · Cited by 92
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction
Zhang, W. R., Craven, T. E., Malhotra, R., Cheung, A. K., Chonchol, M., Drawz, P. E., Sarnak, M. J., Parikh, C. R., Shlipak, M. G., & Ix, J. H. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1037 · Cited by 94
Chronic Kidney Disease and Dietary Measures to Improve Outcomes
Akchurin, O. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.09.007 · Cited by 91
Review of the efficacy of AST-120 (KREMEZIN ® ) on renal function in chronic kidney disease patients
Asai, M., Kumakura, S., & Kikuchi, M. (2019) · Renal Failure · doi:10.1080/0886022x.2018.1561376 · Cited by 91
van de Wouw, J., Broekhuizen, M., Sorop, O., Joles, J. A., Verhaar, M. C., Duncker, D. J., Danser, A. H. J., & Merkus, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01108 · Cited by 97
Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients
Chiurchiu, C. R., Remuzzi, G., & Ruggenenti, P. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110968 · Cited by 91
Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney Disease
Chawla, V., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Sarnak, M. J., & Menon, V. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01450210 · Cited by 91
Self-citationHsu, S. I., & Couser, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070032.58017.20 · Cited by 91
Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?
Gregg, L. P., & Hedayati, S. S. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.007 · Cited by 93
Wen, C. P., Matsushita, K., Coresh, J., Iseki, K., Islam, M., Katz, R., McClellan, W., Peralta, C. A., Wang, H., de Zeeuw, D., et al. (2014) · Kidney International · doi:10.1038/ki.2013.553 · Cited by 91
Self-citationApplication of Branched-Chain Amino Acids in Human Pathological States: Renal Failure ,
Cano, N., Fouque, D. P., & Leverve, X. M. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.299s · Cited by 90
Modification of cardiovascular risk in hemodialysis patients: An evidence‐based review
Johnson, D. W., Craven, A., & Isbel, N. M. (2007) · Hemodialysis International · doi:10.1111/j.1542-4758.2007.00146.x · Cited by 89
Gualano, B., Ugrinowitsch, C., Novaes, R. B., Artioli, G. G., Shimizu, M. H., Seguro, A. C., Harris, R. C., & Lancha, A. H. (2008) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0669-3 · Cited by 88
Validating a case definition for chronic kidney disease using administrative data
Ronksley, P. E., Tonelli, M. A., Quan, H., Manns, B., James, M. T., Clement, F. M., Samuel, S. M., Quinn, R. R., Ravani, P., Brar, S., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr598 · Cited by 89
Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun, G. J., Itakura, Y., Albouze, G., Christophe, J. L., Man, N. K., Grünfeld, J., & Jungers, P. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v661634 · Cited by 88
Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment
Toto, R. D., Shultz, P. J., Raij, L. R., Mitchell, H. C., Shaw, W. C., Ramjit, D. R., Toh, J., & Shahinfar, S. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.684 · Cited by 88
BP Control and Long-Term Risk of ESRD and Mortality
Ku, E., Gassman, J., Appel, L. J., Smogorzewski, M., Sarnak, M. J., Glidden, D. V., Bakris, G., Gutiérrez, O. M., Hebert, L. A., Ix, J. H., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030326 · Cited by 88
Treatment approach to type 2 diabetes: Past, present and future
Blaslov, K., Naranđa, F. S., Kruljac, I., & Renar, I. P. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i12.209 · Cited by 99
Nutritional management in patients with chronic kidney disease
Kim, S. M., & Jung, J. Y. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.408 · Cited by 112
Sarnak, M. J., Poindexter, A. E., Wang, S.-R., Beck, G. J., Kusek, J. W., Marcovina, S. M., Greene, T., & Levey, A. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00677.x · Cited by 87
Self-citationFiltration Markers May Have Prognostic Value Independent of Glomerular Filtration Rate
Tangri, N., Inker, L. A., Tighiouart, H., Sorensen, E. S., Menon, V., Beck, G. J., Shlipak, M. G., Coresh, J., Levey, A. S., & Sarnak, M. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070663 · Cited by 83
Self-citationTreatment of Hypertension in Chronic Kidney Disease
Toto, R. D. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.05.016 · Cited by 87
Dussol, B., Moussi‐Francès, J., Morange, S., Somma-Delpéro, C., MUNDLER, O., & Berland, Y. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00564.x · Cited by 85
Drug Administration in Patients with Renal Insufficiency Minimising Renal and Extrarenal Toxicity
Matzke, G. R., & Frye, R. F. (1997) · Drug Safety · doi:10.2165/00002018-199716030-00005 · Cited by 84
Moore, L. W., Byham-Gray, L. D., Parrott, J. S., Radler, D. R., Mandayam, S. A., Jones, S. L., Mitch, W. E., & Gaber, A. O. (2013) · Kidney International · doi:10.1038/ki.2012.420 · Cited by 86
Metadata
- Authors
- Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G.
- Affiliations
- National Institutes of Health (US)
- Tufts Medical Center (US)
- Cleveland Clinic (US)
- University of Pittsburgh (US)
- University of Iowa Hospitals and Clinics (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-03-31
- Volume
- 330
- Issue
- 13
- Pages
- 877-884
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2321986725
- Semantic Scholar
- 01e2c22d0073b85c7e2ba3a9327f2c898329d6af
- Cited by
- 2,328
- References
- 30
- Citations by year
- 2026: 25 · 2025: 53 · 2024: 56 · 2023: 66 · 2022: 64 · 2021: 74 · 2020: 73 · 2019: 82 · 2018: 81 · 2017: 98 · 2016: 82 · 2015: 84 · 2014: 100 · 2013: 92 · 2012: 92
- FWCI
- 51.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, protein restriction, very low protein diet, low-protein diet, blood pressure control, hypertension, glomerular filtration rate decline, end-stage renal disease, proteinuria, renal failure, disease progression, mortality, renal function decline, end-stage renal disease prevention, mortality prevention
- MeSH terms
- Blood Pressure, Chronic Disease, Dietary Proteins, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Hypertension, Kidney Diseases, Kidney Failure, Chronic, Polycystic Kidney Diseases, Male, Middle Aged, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review